Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: A randomized, double-blind, placebo-controlled study

Respirology

Volumn 18, Issue , 2013, Pages 47-52

  Chen, Ai Huan ^a   Zeng, Guang Qiao ^a   Chen, Rong Chang ^a   Zhan, Jie Yi ^a   Sun, Li Hong ^a   Huang, Shun Kai ^a   Yang, Cui Zhen ^a   Zhong, Nanshan ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Acute exacerbation; Bronchial asthma; Child; Nebulized corticosteroid

Indexed keywords

BUDESONIDE; IPRATROPIUM BROMIDE; PLACEBO; PREDNISONE; SALBUTAMOL; CORTICOSTEROID;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SINGLE DRUG DOSE; ACUTE EXACERBATION; ASIAN; CHINA; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; INHALATIONAL DRUG ADMINISTRATION; NEBULIZED CORTICOSTEROID; NEBULIZER; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ACUTE EXACERBATION; BRONCHIAL ASTHMA; CHILD; NEBULIZED CORTICOSTEROID;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; BUDESONIDE; CHILD; CHINA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84896319733     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12168     Document Type: Article

References (22)

1. Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA), 2011. Available from URL: http://www.ginasthma.org
2. Schuh S, Reisman J, Alshehri M et al. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N. Engl. J.Med. 2000; 343: 689-94.
3. Volovitz B, Bentur I, Finkelstein Y et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J. Allergy Clin. Immunol. 1998; 102: 605-09.
4. Upham BD, Mollen CJ, Scarfone RJ et al. Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. Acad. Emerg. Med. 2011; 18: 665-73.
5. Respiratory Society of Chinese Medical Association. National collaboration for prevention and treatment of childhood asthma. Guideline for prevention and treatment of childhood asthma (pilot version). Chin. J. Pediatr. 2004; 42: 100-4.
6. Morice AH, Morris D, Lawson-Matthew PA. Comparison of nebulized budesonide with oral prednisonlone in the treatment of exacerbation of obstructive pulmonary disease. Clin. Pharmacol. Ther. 1996; 60: 675-78.
7. Maltais F, Ostinelli J, Bourbeau J et al. Comparison of nebulized budesonide and oral prednisonlone with placebo in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Am. J. Rev. Respir. Crit. Care.Med. 2002; 165: 698-703.
8. Beasley R, Sterk PJ, Kerstjens HA et al. Comparative studies of inhaled corticosteroids in asthma. Rur.Respir. J. 2001; 17: 579-80.
9. Rodrigo G, Rodrigo C. Corticosteroids in the emergency department therapy of acute adult asthma: an evidence-based evaluation. Chest 1999; 116: 285-95.
10. Rowe BH, Spooner C, Ducharme FM et al. Early emergency department treatment of acute asthma with systemic corticosteroids (update). Cochrane Database Syst. Rev. 2001; (1): CD002178.
11. Wolthers OD, Riis BJ, Pedersen S. Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. Pediatr. Pulmonol. 1993; 16: 341-46.
12. Dolan LM, Kesarwala HH, Holroyde JC et al. Short-term, highdose, systemic steroids in children with asthma: the effect on the hypothalamic-pituitary-adrenal axis. J. Allergy Clin. Immunol. 1987; 80: 81-7.
13. Decimo F, Maiello N, Miraglia Del Giudice M et al. High-dose inhaled flunisonlide versus budesonide in the treatment of acute asthma exacerbation in preschool-age children. Int. J. Immunopathol. Pharmacol. 2009; 22: 363-70.
14. Edlger D, Coskun F, KuntUzaslan E et al. Clinical effectiveness of nebulized budesonide in the treatment of acute asthma attacks. Tuberk. Toraks 2006; 54: 128-36.
15. Raze CH, Turktas I, Bakirtas A. Comparison of single 2000-microg dose treatment vs. sequential repeated-dose 500-microg treatments with nebulized budesonide in acute asthma exacerbations. Ann. Allergy Asthma Immunol. 2008; 100: 370-76.
16. Tsai YG, Lee MY, Yang KD et al. A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma. J. Pediatr. 2001; 139: 433-37.
17. Volovitz B. Inhaled budesonide in the management of acute worsenings and exacerbations of asthma: a review of the evidence. Respir.Med. 2007; 101: 685-95.
18. De Benedictis FM, Miraglia Del Giudice M et al. Flic12 Study Group. Nebulized fluticasone propionate vs. budesonide as adjunctive treatment in children with asthma exacerbation. J. Asthma 2005; 42: 331-36.
19. Sekerel BE, Sackesen C, Tuncer A et al. The effect of nebulized budesonide treatment in children with mild to moderate exacerbations of asthma. Acta Paediatr. 2005; 94: 1372-77.
20. Higenbottam TW, Britton J, Lawrence D et al. Comparison of nebulized budesonide and prednisolone at severe asthma exacerbation in adults. Biol. Drugs 2000; 14: 247-54.
21. Devidayal S, Singhi S, Kumar L et al. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta. Pediatr. 1999; 88: 835-40.
22. Nuhoglu Y, Atas E, Nuhoglu C et al. Acute effect of nebulized budesonide in asthmatic children. J. Invest. Allergol. Clin. Immunol. 2005; 15: 197-200.